EP0689542A1

EP0689542A1 - Process for the preparation of condensed carbapeneme derivatives

Info

Publication number: EP0689542A1
Application number: EP94911906A
Authority: EP
Inventors: Gian Luca Araldi
Original assignee: Glaxo SpA
Current assignee: GlaxoSmithKline SpA
Priority date: 1993-03-20
Filing date: 1994-03-17
Publication date: 1996-01-03
Also published as: NO953697D0; NO953697L; WO1994021637A1; HUT73486A; CA2157787A1; FI954399A0; JPH08507776A; PL310620A1; HU9502738D0; AU6427294A; CN1119864A; FI954399A; GB9305813D0

Abstract

A process for the preparation of the antibacterial compound of formula (I) or a salt thereof which comprises the thermal cyclisation of a compound of formula (II), wherein R is a carboxyl protecting group, followed by removal of the said carboxyl protecting group R and if necessary or desired conversion of the resultant carboxylic acid into a salt thereof.

Description

PROCESS FOR THE PREPARATION OF CONDENSED CARBAPENEME DERIVATIVES

The present invention relates to an improved process for the synthesis of an antibacterial agent.

European Patent Application publication No. 0416953A2 describes a novel class of tricyclic antibacterial agents and processes for their preparation. A particular preferred compound described therein is the methoxy derivative (I)

and salts thereof. EPA 0416953A2 also teaches that the compound of formula

(I) may be prepared by the process as outlined below:-

(I) (C)

wherein R-_{| a} is a hydroxyl protecting group; R2a is a carboxyl protecting group and Y is oxygen or a phosphine group.

More specifically the specification teaches the preparation of compound (I) using intermediates wherein R-| _a is t-butyldimethylsilyl group, Y is oxygen and R2a is allyl or R-| _a is t-butyldimethylsilyl, Y is PPh3 and R2_a is benzyl.

It has unexpectedly been found that the conversion of the lactam (A), wherein Y is a phosphine group into the required tricyclic antibacterial agent (I) can be significantly improved if the hydroxyl protecting group R-| _a is removed prior to the cyclisation step in the synthesis.

Thus the present invention provides a process for the preparation of the compound of formula (I)

and salts thereof which comprises the thermal cyclisation of the lactam (II)

(ID wherein R is a carboxyl protecting group followed by removal of the carboxyl protecting to give either the free carboxylic acid or a physiologically acceptable salt thereof. Suitable carboxyl protecting groups R include allyl or arylmethyl such as benzyl, t-butylbenzyl, diphenylmethyl or p-biphenylmethyl.

The thermal cyclisation process is preferably carried out by heating the compound of formula (II) in a solvent at a temperature within the range 40- 200°-. Examples of suitable solvents include hydrocarbons such as toluene or xylene, ethers such as tetrahydrofuran or 1 ,4-dioxan or an alkanol e.g. propanol or isopropanol, or esters such as ethyl acetate or mixtures of two or more such solvents.

The carboxyl protecting group R may be removed by standard processes such as those described in Protective Groups in Organic Chemistry, pages 192-210, Edited by J F W McOmie (Plenum Press 1983). For example when R represents an arylmethyl group this may be removed by conventional procedures using hydrogen and a metal catalyst e.g. palladium in a suitable solvent such as an alkanol e.g. propanol and preferably in the presence of a tertiary amine such as a trialkylamine e.g. triethylamine.

When the group R represents an allyl group then this is preferably removed by treatment with an allyl acceptor in the presence of tetrakis(triphenylphospine) palladium and optionally in the presence of triphenylphospine. Suitable allyl acceptors include sterically hindered amines such as t-butylamine, cyclic secondary amines such as morpholine or thiomorpholine, tertiary amines such as triethylamine, aliphatic or cycloaliphatic β-dicarbonyl compounds such as acetylacetone, ethyl acetoacetate or dimedone, or alkanoic acids or alkali metal salts thereof such as acetic acid, propionic acid or 2-ethyl hexanoic acid or the potassium or sodium salt thereof. The reaction is preferably carried out in an inert solvent such as an ether e.g. diethyl ether or tetrahydrofuran, an alkanol e.g. ethanol, or propanol, an ester e.g. ethyl acetate or a halohydrocarbon e.g. methylene chloride, or mixtures thereof. The reaction is conveniently carried out in the temperature range 0-40° more particularly at room temperature.

In a preferred aspect of the invention the thermal cyclisation is carried out using a compound of formula (III) wherein R is an arylmethyl group such as benzyl or p-t-butylbenzyl and at a temperature within the range 40-120° and in a solvent such as a hydrocarbon e.g. toluene, an ether e.g. 1 ,4-dioxan or an alkanol e.g. propanol or isopropanol or an ester e.g. ethylacetate or a mixture thereof with an alkanol. The arylmethyl carboxyl protecting group R is preferably removed by hydrogenolysis using hydrogen and a metal catalyst such as palladium and in a solvent such as an alkanol e.g. ethanol, isopropanol, esters e.g. ethyl acetate or ketone e.g. acetone and in the presence of a base. Suitable bases for use in the reaction include tertiary organic bases such as trialkylamines e.g. triethylamine. The carboxylic acid (I) or a salt thereof may conveniently be converted into a physiologically acceptable salt thereof without isolation of the product of the hydrogenolysis. Thus for example the sodium salt thereof may be obtained by the addition of acetone and sodium ethylhexanoate to the reaction solution, followed by addition of a non solvent such as an ether e.g. diisopropyl ether. In this process it may be advantageous to add seed crystals of the required sodium salt.

Salts of the compound of formula (I) include physiologically acceptable salts thereof and non physiologically acceptable salts thereof.

Suitable physiologically acceptable salts of compound of formula (I) include salts formed with alkali metals e.g. sodium or potassium, alkaline earth metals e.g. calcium, amino acids (e.g. lysine and arginine) and organic bases (e.g. procaine, phenylbenzylamine, ethanolamine, diethanolamine and N-methyl glucosamine). Non physiologically acceptable salts of the compound of formula (I) may be useful as intermediates for the preparation and/or isolation of the compound of formula (I) or a physiologically acceptable salt thereof.

The hydroxy compounds of formula (II) which are novel and represent another aspect of the invention may be prepared from the corrresponding ether (III)

C0₂R

(III)

wherein H-\ is a trialkylsilyl group and R is as defined in formula (II) by conventional procedures. Thus if R-| is a t-butyldimethysilyl group this may be removed by treatment with tetrabutyiammonium fluoride and acetic acid in a solvent such as tetrahydrofuran or by hydrolysis with a mineral acid such as hydrochloric acid in a suitable organic solvent, for example acetonitrile and acetic acid.

The silylethers of formula (III) are either known compounds or may be prepared by the procedures described in EPA No. 0416953A2 and or the examples given below.

In order that the invention may be more fully understood the following examples are given by way of illustration only.

In the intermediates and examples all temperatures refer to OC; solutions were dreid refers to solutions dried over anhydrous sodium sulphate.

Intermediate 1

Ren₇yl 2-[3S.4RV3[fR -1-(t-butyldimethylsilyloxy')ethyl]-4- (2'S.6^,RV2-methoxy- 1 "-nxocyrtohexy-6"-yl]azetidin-2-on-1 -yl]-2-triphenylphosphoranyl acetate

To a solution of (3S,4R)-3[(R)-1 -(t-Butyldimethylsilyioxyethyl]-4[(R)-2'-(S)-6- methoxy-1 '-oxocyclohexyl)]azetindin-2-one (4.5g) in dry tetrahydroduran (15ml) under nitorgen, benzyl glyoxylate (2.4g) triethylamine (0.5ml) and 3A molecular sieves were added.The reaction mixture was stirred at 22° for 24hrs then diluted with ethyl acetate (100ml), washed with saturated aq. ammonium chloride (2x100ml), brine (2x200ml), dried and concentrated under vacuum. The oily residue (6.4g) was dissolved in dry tetrahydrofuran (100ml) under nitrogen at 0°, and thionyl chloride (1.84ml) and 2,6-lutidine (3.20ml) were added. The reaction mixture was stirred at 22° for 4 hrs, diluted with ethyl acetate (100ml), washed with saturated aq. ammomium chloride (2x150ml), 5% aq. sodium hydrogen carbonate (2x150ml), brine (2x150ml), dried and concentrated under vacuum. The oily residue (6.2g) was dissolved in 1 ,4-dioxane (50ml) and 2,6-lutidine (2.2ml) sodium bromide (2.6g) and triphenylphospine (6.64g) were added.The reaction mixture was stirred at 22° for 15hrs, then poured into saturated aq. ammonium chloride (200ml) and extracted with ethyl acetate (200ml). The organic layer was washed with saturated aq. ammonium chloride (200ml) and brine (2x200ml), dried and concentrated under reduced pressure. The oily resiude was chromatographed on silica gel using light petroleum/diethyl ether 1/1 as eluant, to give the title compound as a white solid (5.04g) m.p. =128°; t.l.c. ethyl acetate. cyclohexane 1/1 Rf = 0.6).

Example 1 Benzyl (4S.8S.9R.10S.12R)-4-methoxy-10-(-1 -hydroxyethyll-l 1 -oxo-1 - azatricvclol7.2.0.0^1undec-2-ene-2-carboxylate

To a solution of the intermediate 1 (3.7g) in acetonitrile (100ml), acetic acid (4.8ml) and 37% hydrochloric acid (3.73ml) were added with ice cooling.The reaction mixture was stirred at -15° for 1 hr. poured into cold 5% aq. sodium hydrogen carbonate (200ml) and extracted with ethyl acetate (200ml). The organic layer was washed with brine (2x200ml), dried and concentrated under reduced pressure to give enzyl 2-[3S,4R)-3[(R)-1 -(hydroxyethyl)-4-[(2'S,6'R)-2- methoxy-1 "-oxocyclohexy-6"-yl]azetidin-2-on-1 -yl]-2-triphenylphosphoranyl acetate as a white foam which was dissolved in 1 ,4-dioxan (30ml) and heated at reflux for 7hrs. The solution was diluted with ethyl acetate (100ml) and washed with saturared aq. ammonium chloride (2x100ml) and brine (2x100ml) and washed with saturated aq. ammonium chloride (2x100ml) and brine (2x100ml), dried and concentrated under vacuum. The oily residue was chromatographed on silica gel, using ethyl acetate/cyclohexane 1/1 as eluant, to afford the title compound as a foam (0.59g; t.l.c. ethyl acetate/cyclohexane 1/1 Rf=0.3).

IR (CDCy V _maxcnr¹ : 3600 (O-H), 1772(C=0 β lactam), 1718(C=0 ester), 1632(C=C); ¹ H-NMR (300MHz, CDCI₃): 7.47-7.30(m), 5.29(dd), 4.94(t), 4.24(m), 4.19(dd),

3.3-3.2(m), 3.20(s), 2.05(m), 1.9-1.2(m), 1.61 (d), 1.32(d).

Example 2

4-t-Butylbenzyl (4S.8S.9R.10S.12R -methoxy-10-M -hvdroxyethyl )-11 -oxo-1 - azatricvclo[7.2.0.0^a^]undec-2-ene-2-carboxylate

fi -t-Butylbenzyl-2f3S.4S)-3[(R)-1 -(hvdroxyethyl)-4-[(2'S.6^,R 2-methoxy- 1 "oxocvclohexy-6"-yl]azetidin-2-on-1-yl1-2- triphenylphosphoranyl acetate 2,6-Lutidine (3.95 g) was added to a solution of (3S,4R)-3[(R)-1 - (tbutyldimethylsilyloxyethyl]-4(R)-2'(S)-6-methoxy-1 '-oxocyclohexyl)]azetidin-2- one (5.0 g) and 4-t-butylbenzylglyoxylate (4.51 g) in ethyl acetate (50 ml) and the resultant solution was heated to reflux. Ethyl acetate (10 ml) was removed by distillation and the resultant solution was heated at reflux for 6 hours. The reaction was cooled to 0-5°, thionyl chloride (2.05 ml) in ethyl acetate (10 ml) was added over 30 min. and the reaction mixture was stirred at 0-5° for 45 min. The reaction was quenched by dropwise addition of an 8% solution of sodium bicarbonate (70 ml), the resultant mixture was stirred at 5° for 30 min and then the phases were separated. The aqueous layer was re-extracted with ethyl acetate (15 ml) and the combined organic phases were washed with 1 M a solution of citric acid (40 ml), water (20 ml) and brine (20 ml). The organic solution was treated with 2,6-lutidine (2.5 ml), sodium bromide (2.25 g) and triphenylphosphine (5.7 g). The resultant mixture was stirred at 25 C for 20 hours after that was washed with 1 M solution of citric acid (25 ml), water (25 ml) and brine (3x50 ml). The organic phase was evaporated under vacuum to give a light brown foam (13.8 g) of 4-t-butylbenzyl-2(3S,4S)-3[(R)-1 -(t- butyldimethylsilyloxy)ethyl]-4-[(2'S,6'R)-2-methoxy-1 "oxocyclohexy-6"- yl]azetidin-2-on-1 -yl]-2- triphenylphosphoranyl acetate ,which was dissolved in a mixture of cyclohexane (138 ml), ethyl acetate (27 ml) and tetrahydrofuran (91 ml) and the resultant solution cooled at 0-5° with stirring. Cold 4M hydrochloric acid (262 ml) was added over 15 min whilst maintaining a temperature of 0-5° and the biphasic mixture was stirred for 1 hour at 2-5°. The phases were separated, the aqueous layer was washed with a mixture of cyclohexane (138 ml) and ethyl acetate (27 ml), and then basified at 5° by addition of a 4M solution of potassium carbonate (215 ml). The aqueous layer was extracted with ethyl acetate (2x165 ml), dried and evaporated under vacuum to give a foam (3.27 g) which foam was dissolved in methyl ethyl ketone (60 ml). To the cooled (0°) solution was added dropwise, over 30 min., n-hexane (275 ml) with vigorous stirring and under nitrogen atmosphere. The mixture was stirred at 0-5° for 1 hour and then filtered. The solid was washed with a n-hexane/methyl ethyl ketone (55 ml / 11.7 ml) mixture and then dried to give the title compound as solid(4.35 g).

(t.l.c. ethyl acetate; Rf = 0.35) IR ( film ) V_max (cm^"1 ) 3468 (O-H) 1745 (C=0 b lactam) 1651-1618 (C=0 , C=C)

¹ H -NMR (300MHz, CDCI3) : 7.20-7.28 (m), 7.10-7.00 (m), 6.70-6.56 (m), 5.10 (m), 4.96-4.56 (m), 4.07 (m), 4.00-3.66 (m), 3.47 (m), 3.26 (s), 3.12 (s), 3.08 (s), 3.00-2.84 (m), 2.71 (m), 2.52-1.80 (m), 1.70-1.50 (m), 1.44-1.20 (m), 1.25 (d), 1.02 (d)

(\\) 4-t-Butylbenzyl(4S.8S.9R.10S.12R)-4-methoxy-10-H -hydroxyethylH 1 -oxo-

1 -azatricvclor7.2.0.θ ]undec-2-ene-2-carboxvlate

A solution of the compound of Example 2(i) (1.3 g) in toluene (52 ml) was heated at reflux for 13 hours and then concentrated under reduced pressure. The oil was dissolved in tertbutylmethylether (25 ml) and the organic solution was washed three times with 1/1 DMF/water mixture (25 ml). The organic layer was diluted with tertbutylmethylether (10 ml), washed with water (3x25 ml), dried and evaporated to give the title compound (0.7g) as a yellow foam. (t.l.c. diethylether; Rf = 0.32)

¹ H -NMR (300MHz, CDCI3) : 7.38 (s), 5.34 (d), 5.19 (d), 4.95 (t), 4.21 (m), 4.17 (dd), 3.25 (dd), 3.23 (m), 3.21 (s), 2.06 (m), 1.86 (m), 1.77 (d), 1.60 (m), 1.40 (m), 1.32 (d), 1.31 (s). Example 3

Sodium(4S.8S.9R.10S.12R .-4-methoxy-10⁽1 -hydroxyethyl)-11 -oxo-1 - azatricvclo[7.2.00³ _^S]undec-2-ene-2-carboxylate

10% palladium on carbon (0.86 g) was added to a solution of Benzyl(4S,8S,9R,10S.12R)-4-methoxy-10-(1 -hydroxyethyl)-11 -oxo-1 - azatricyclo[7.2.0.0-³-⁸ ]undec-2-ene-carboxylate (300 mg) in tetrahydrofuran (10 ml), under nitrogen. The mixture was then hydrogenated at 25-26 °C and 1 atm for 20 min. and after that, the catalyst filtered off and washed with diethyl ether (10 ml). Sodium 2-ethylhexanoate (0.134 g) was added to the filtrate followed by diethyl ether (100 ml). The white suspension was stirred at 0 ° under nitrogen for 1 hr. The solid was filtered off, washed with diethyl ether (5 ml) and dried under vacuum to give the title compound (0.115 g) as a white solid. ¹ H-NMR (300MHz) (D₂0): 4.74 (m), 4.10 (m), 4.03 (dd), 3.31 (dd), 3.11 (s), 3.03 (m), 1.90(m), 1.75 (m), 1.6-1.2 (m), 1.13 (m).

Example 4

Sodium(4S.8S.9R.10S.12RV4-methoxyV1 OM -hvdroxysthyl)-11 -oxo-1 - azatricvclo[7.2.0θ ]undec-2-ene-2-carhoxvlate

10% Palladium on carbon (0.2g) and triethylamine (0.23ml) were added to a solution of t-butylbenzyl(4S,8S,9R,10S,12R)-4-methoxy-10-(1 -hydroxyethyl)-11 - oxo-1 -azatricyclo[7.2.0.0-³-8 ]undec-2-ene-carboxylate (0.5 g) in n-propanol (5ml) under nitrogen. The mixture was then hydrogenated at room temperature and 1 atm for approximately 40 min. The catalyst was filtered off washed with acetone (2 ml). Sodium 2-ethylhexanoate (0.29 g) was added to the combined filtrates and, after few minutes, diisopropylether (20 ml) was added dropwise and the mixture seeded. The white suspension was stirred at room temperature under nitrogen for approximately 2 hrs, the solid was filtered off, washed with a 10/2.5/1 mixture of diisopropylether/n-propanol/acetone (1 ml) and dried under vacuum, the to give title compound (0.115 g) as a white solid.

Example 5

Sodium(4S.8S.9R.10S.12RV4-methoxy-10(1 -hvdroxyethylVI 1 -oxo-1 - azatricvclo[7.2.0θ ]undec-2-ene-2-carboxvlate

A solution of benzyl 2-(3S,4R)-3[(R)-1-(hydroxyethyl)-4-[(2'S,6'S)-2-methoxy-1 "- oxoocyclohexy-6"-yl]azetidin-2-on-1-yl]-2-triphenylphosphoranyl acetate (20 g) in 1 -propanol (300 ml) was heated at reflux for 3 hrs. After cooling the solvent was evaporated under vacuum, 2-propanol (120 ml) was added and the solution was concentrated to give crude benzyl(4S,8S,9R,10S,12R)-4-methoxy-10-(1- hydroxyethyl9-1 1 -oxo-1 -azatricyclo[7.2.0.0-³-⁸ ]undec-2-ene-carboxylate as an oil (20g). 10% Palladium on carbon (4.8 g) and triethylamine (4.6 ml) were added to a solution of the oil in 2-propanol (300 ml), under nitrogen. The obtained mixture was then hydrogenated at 25-26 °C and 1 atm for 35 min. The catalyst was filtered off washed with acetone (100 ml) and the combined filtrate concentrated to 100 ml. A solution of sodium 2-ethylhexanoate (5.8 g) in acetone (40 ml) was added to the concentrate followed by the dropwise addition of diisopropylether (400 ml) over approximately 30min. The white suspension was stirred at room temperature under nitrogen for 1.5 hrs, the solid is filtered off, washed with diisopropylether (2x25 ml) and dried under vacuum to give the title compound (5.35 g) as a white solid. IR (nujol) V_max (cm^"1); 3387 (OH), 1776-1726 (C=0), 1616-1587 (C=C)

Claims

A process for the preparation of the compound of formula (I)

or a salt thereof which comprises the thermal cyclisation of a compound of formula (II)

(II)

wherein R is a carboxyl protecting group, followed by removal of the said carboxyl protecting group R and if necessary or desired converting the resultant carboxylic acid into a salt thereof.

2. A process as claimed in Claim 1 wherein the thermal cyclisation is carried out in a solvent.

3. A process as claimed in Claims 1 or 2 wherein the solvent is selected from a hydrocarbon, ether, alkanol or ester or a mixture of 2 or more such solvents.

4. A process as claimed in any of claims 1 to 3 wherein the cyclisation is carried out at a temperature within the range 40-200°C.

5. A process as claimed in any of Claims 1 to 4 wherein the carboxyl protecting group R is an arylmethyl group.

6. A process as claimed in Claim 5 wherein the carboxyl protecting group is removed by hydrogenolysis.

7. A process as claimed in any of Claims 1 to 6 wherein the compound of formula (I) is isolated in the form of a physiologically acceptable salt thereof.

8. The compound of formula (I) or a salt thereof whenever prepared by a process as claimed in any of Claims 1 to 7.

9. Sodium (4S, 8S, 9R, 10S, 12R)-4-methoxy-10-(1-hydroxyethyl)-11- oxo-1 -azatricycio [7.2.0.0.³-⁸]undec-2-ene-2-carboxylate whenever prepared by a process as claimed in any of Claims 1 to 7.

10. The benzyl or 4-t-butylbenzyl ester of the compound of formula (I) whenever prepared by the thermal cyclisation of a compound of formula (II) wherein R is a benzyl or 4-t-butyIbenzyl group.